ROIV · Roivant Sciences Ltd.
$36.20
-0.08 (-0.22%)
At close · Aug 14
Market Cap
$26.15B
Shares
722.32M
Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.
Remaining Authorization
$681,700,000
as of 2026-06-30
Program Utilization
31.8%
$318,300,000 used of $1,000,000,000
Repurchase Programs
Equity Offering (ATM) Programs
| Program Established | Last Amended | Capacity | Remaining | Runs Through | Source |
|---|---|---|---|---|---|
| 2022-09-19 | — | $400,000,000 | $400,000,000 as of 2026-06-30 | — | 10-Q , filed 2026-08-06 |
Cash spent on buybacks by quarter
Cash deployed each quarter. Δ marks quarters derived from the company's cumulative year-to-date disclosures.
Repurchase History
| Fiscal Year Ended | Cash Spent | Source | ||
|---|---|---|---|---|
| 2025-12-31 YTD | $208,293,000 | 10-Q, filed 2026-02-06 | ||
| 2025-03-31 | $1,293,232,000 | 10-K, filed 2025-05-29 | ||
Key facts
CIK
1635088
CUSIP
G76279101
13F (30d)
472 filings
454 filers
Visit website
Investor relations